Biocartis welcomes new CEO

Biocartis Group has appointed Herman Verrelst as its new Chief Executive Officer (CEO), effective as of August 2017.

Herman currently holds the position of Vice President and General Manager of the Genomics and Clinical Applications Division of Agilent Technologies.

Herman Verrelst added: “I am passionate by growth stories that are driven by true innovation and as such very pleased to be given the opportunity to join Biocartis. I look forward to work with the team and with Rudi Pauwels, whose passion and vision I share, to continue to disrupt the molecular diagnostics market with solutions that bring precision medicine into practice. The Idylla(TM) platform is an extremely elegant and best-in-class platform to achieve this goal.”